Ticagrelor With Low-dose Versus Regular Aspirin in Patients With Acute Coronary Syndrome (ACS) at High-Risk for Ischemia After Percutaneous Coronary Intervention
Conditions: Acute Coronary Syndrome; Interventional Cardiology Interventions: Drug: Aspirin; Drug: Ticagrelor Sponsor: Fu Wai Hospital, Beijing, China Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Angioplasty | Aspirin | Cardiology | China Health | Coronary Angioplasty | Heart | Hospitals | Percutaneous Coronary Intervention | Research